2019 Speakers

more speakers and panellists to be announced

  • Dr. Andrew Feilden

    Chemistry Operations Director Smithers Rapra

    Andrew Feilden joined Smithers Rapra as a Principal Consultant in June 2011 and was appointed Chemistry Operations Director in October 2012. He specializes in extractable and leachable testing and the selection and assessment of materials for medical and pharmaceutical applications. Andrew previously worked at AstraZeneca for 12 years, leading their extractable and leachable testing. He has been working in the field of trace analysis using hyphenated techniques such as GC-MS and LC-MS for over 12 years. Whilst at AstraZeneca he was an active member of industry working groups, the IPAC-RS container closure group and he was the co-chair of ELSIE material group. Andrew gained a degree and D.Phil from York University.

  • Luo Hongyu

    Senior Scientist Baxter Healthcare Company, China

    She has more than 20 years experiences in technical assessment and safety evaluation for medical devices and pharmaceutical packages industry. Before joining Baxter, as the director of Chemistry department in CFDA Jinan Quality Supervision and Inspection Center for Medical Devices, Shandong Province. 

    Led drafting a number of national and industrial standards on medical devices and pharmaceutical packages. Coauthored and published 4 professional books as well as more than ten articles.

    Served as member of WG14 in ISO/TC 194 Biological Evaluation of Medical Devices; Committee member of National Standardization Technical Committee on Implants for Surgery; Expert of National Science & Technology Ministry.

    骆红宇

    苏州百特医疗用品有限公司研发中心高级科学家。工程应用技术研究员。从事药品包装和医疗器械安全性评价及实验研究20多年,曾任CFDA济南药品包装材料检验中心化学室主任。主持或参与完成多项科技部重点研发项目、国家药典委项目等。完成药品包装及医疗器械国家、行业及协会标准项目数十项,参与编写相关专著4部。

    现任国际标准化组织ISO/TC194第14工作组(医疗器械化学表征)工作组委员、全国外科植入物标准化技术委员会委员、国家科技部在库专家。

  • Kathy Huang

    R&D Manager Becton Dickinson Medical Devices (Shanghai) Co. Ltd., China

    Kathy joined BD as R&D manager of Analytical Chemistry Lab.  She is responsible for Extractable& Leachable research for pre-filled syringe products and medical device; YBB test and materials identification to support internal partner and external customer.

    Prior to joining BD, Kathy worked at Baxter R&D centre. She worked for new packaging material development and doing extractable and leachable research for them. Kathy received Ph.D. in Physical Chemistry from Institute of Chemistry, Chinese Academy of Sciences, Beijing.

  • Dr. Dennis Jenke

    Chief Executive Scientist Triad Scientific Solutions, UK

    Dr. Dennis Jenke is a Baxter Distinguished Scientist in the Technology Resources Division of the Baxter Healthcare Corporation. In this role, he works with a team of analytical chemistry professionals whose primary responsibility includes the development, validation and application of diverse analytical strategies and methods for the discovery, identification and quantification of trace constituents in pharmaceutically relevant solutions and samples. 

  • Dr. Daniel Norwood

    Executive Partner SCIO Analytical & Senior Consultant at Smithers Rapra, UK

    Dr. Daniel Norwood joined SCIO Analytical as Executive Partner in June 2015. Prior to SCIO Analytical, Dr. Norwood was a key technical employee at Boehringer Ingelheim Pharmaceuticals where he was successful in various pharmaceutical development roles, including Director Physical and Chemical Analysis.  In June 2015, Dr. Norwood retired with the title of Distinguished Research Fellow in Analytical Development.  Prior to joining Boehringer Ingelheim, Dr. Norwood, with Dr. Feinberg, founded the Structural Chemistry Group at Magellan Laboratories, later Catalent Pharma Solutions, which became widely recognized for its work in pharmaceutical impurity structure elucidation, and in leachables and extractables characterization. Prior to Magellan, he was a pharmaceutical development scientist at the Glaxo Research Institute.  

    Dr. Norwood is an internationally recognized expert in the field of leachables and extractables assessment in pharmaceutical development and manufacturing.  He served as chair of the widely-quoted Product Quality Research Institute (PQRI) Working Group on leachables and extractables in inhalation drug products. He is also a member of the PQRI Working Group on leachables and extractables in parenteral and ophthalmic drug products (PODP), and has served on various technical teams of the International Pharmaceutical Aerosol Consortium on Regulations and Science (IPAC-RS). Since 2010, he has served as a member of the USP Expert Committee on Packaging, Storage and Distribution where he chairs the subcommittee on extractables and leachables. Dr. Norwood has received several industry awards, including the CEO’s Award from Glaxo (1994), the President’s Award from Boehringer Ingelheim (2007), the Excellence in Research Award from PQRI (2009), and the Award for an Innovative Response to Public Health Challenges from USP (2013). Dr. Norwood completed his bachelor’s degree in Biochemistry at Virginia Tech and his doctorate degree in Environmental Chemistry at the University of North Carolina at Chapel Hill, School of Public Health.

  • Dr. Sherry Parker

    Toxicology Director Fresenius Medical Care, USA

    Dr. Parker has over 19 years of toxicology and medical device research experience, and is an expert in the biological evaluation and toxicological risk assessment of medical devices and combination products.  Dr. Parker graduated with a Doctorate Degree in Molecular and Cellular Pharmacology at University of Miami, has since obtained toxicology experience in academia, government, contract research and medical device industries. In her current position, she is the Toxicology Director at Fresenius Medical Care working in global research and development.   Dr. Parker is a US Delegate in multiple AAMI working groups for ISO/TC194 (the technical committee for ISO 10993), and is an international ISO expert on three working groups (WG 1, 11, and 15). She is the current Vice-President (2018-2019) and soon to be President (2019-2020) for the Medical Device and Combination Products Specialty Section, of the Society of Toxicology.

  • Xiaoxia Ye

    CTO Tiankun Pharma, China

    • Strong instrumentation skills (in charge of calibration, maintenance and troubleshooting of GC-MS and LC-MS for 4 years)
    • 8-year analytical method development and validation experience in the field of mass spectrometry
    • Proficient in qualitative and quantitative GC-MS and LC-MS/MS characterization and identification of biological and non-biological samples
    • Experience on ICP-MS, FTIR, UV-vis, friction flow loop system and wet chemistry
    • Excellent interpersonal skills from the research and teaching assistantship at the University of Alberta

  • Weichun (Wes) Yang

    Senior Scientist II Baxter, China

    Wes joined Baxter in December 2015 as Sr. Scientist II and manager of Suzhou extractable and leachable team at Baxter Suzhou R&D center. Wes’s major responsibilities include leading the Suzhou E&L team to support new product development and launch; maintenance of current products; collaborating with key internal and external partners to achieve operational excellence; future technical direction and capability of the team.

    Prior to Baxter, Wes was the analytical lab manager at Kemin Industries in Des Moines, IA. Before that, Wes worked few years as research associate at University of California, Riverside.

    Wes received his B.S. in Chemistry from Zhejiang University and Ph. D. in Analytical Chemistry from Brigham Young University. Wes published over 30 papers in peer-reviewed journals including Analytical Chemistry and Lab on a Chip.

  • Lynn Yao

    Scientific Affairs Manager, China 科技事务经理,中国 West Pharmaceutical Packaging (China) Co., Ltd. 西氏医药包装(中国)有限公司

    Lynn currently serves as Scientific Affairs Manager (China) in West Pharmaceutical Packaging (China) Co., Ltd., in her role, Lynn helps to review and analyze the industry development as well as the regulatory changes in China for injectable and offer scientific advice.

    Lynn joined West as a Technical Support Engineer, providing technical support in mainland China. Before joining West, Lynn worked in a technical support supervisor role with a company dealing with biochemical and microbiological reagents after she graduated from University with a Master degree in Biochemical Engineering.

    姚雪凌,现供职于西氏医药包装(中国)有限公司,作为科技事务经理(中国),帮助分析行业和市场的发展以及中国注射剂法规的变化,提供科学性建议。

    姚雪凌起初作为技术支持工程师加入西氏,向中国大陆区客户提供技术支持。她在加入西氏之前,在获得获得生物化工硕士学位后,作为技术支持部门主管在一家生物化学和微生物试剂公司工作。